• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 30525
Device Problems Calcified (1077); Perivalvular Leak (1457); Structural Problem (2506)
Patient Problems Death (1802); Hemorrhage, Cerebral (1889); Thromboembolism (2654)
Event Date 02/01/2016
Event Type  Death  
Manufacturer Narrative
Title: the mosaic mitral valve bioprosthesis: a long-term clinical and hemodynamic follow-up citation: heart inst j 2016;43(1):13-9) authors: michele celiento, md, stefania blasi, md, andrea de martino, md, stefano pratali, md, aldo d.Milano, md, phd, uberto bortolotti, md.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether this event has been previously reported.(b)(4).
 
Event Description
Medtronic received information via literature review of a retrospective study performed to evaluate patients who underwent isolated mitral valve replacements from (b)(6) 1995 through (b)(6) 2011.The study population included 100 patients (predominantly male; mean age 73 ± years), all of which were implanted with a medtronic mosaic bioprosthetic valve (serial numbers not provided).Among all patients, 41 deaths occurred, 10 in-hospital deaths and 31 late deaths.Causes of death included: 8 cardiac, 2 cerebral embolism, 2 reoperation, and 1 unexpected.Of these deaths, five were deemed valve-related.Additionally, the following adverse events occurred: 4 thromboembolism, 1 cerebral hemorrhage, 3 cerebral embolic episodes, and 2 structural valve dysfunction (svd).Four patients required re-operation due to 2 svd (regurgitation, valve dehiscence, calcification and cuspal tear), 1 paravalvular leak (pvl), and 1 valve thrombosis.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Corrected information: sex.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOSAIC AORTIC BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e. deere ave.
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e. deere ave.
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key5583474
MDR Text Key42848215
Report Number2025587-2016-00525
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P990064
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/11/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/17/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number30525
Device Catalogue Number30525
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/11/2016
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Required Intervention;
Patient Age00073 YR
-
-